An update of the Grützbalg hypothesis: The role of thrombosis and coagulation in atherosclerotic progression

Thrombosis and Haemostasis

Volumn 85, Issue 2, 2001, Pages 207-217

  Yee, K O ^a   Ikari, Y ^a   Schwartz, S M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Coagulation; Plaque rupture; Remodelling

Indexed keywords

FAS LIGAND; FIBRIN; LIPID;

ANEURYSM RUPTURE; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; CHRONIC DISEASE; DISEASE COURSE; DISEASE MODEL; FIBRIN FORMATION; HUMAN; LIPID STORAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE; THROMBOSIS; VASCULAR DISEASE; WOUND CONTRACTION;

EID: 0035126098     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615678     Document Type: Review

References (138)

1. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice
2. Fibrinogen deficiency is compatible with the development of atherosclerosis in mice
3. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions
4. Autoradiographic analysis of the distribution of 125I-tyramine-cellobiose-LDL in atherosclerotic lesions of the WHHL rabbit
5. Accumulation of 125I-tyramine cellobiose-labeled low lipoprotein is greater in the atherosclerosis-susceptible region of White Carneau pigeon aorta and further enhanced once atherosclerotic lesions develop
6. Role of arterial lipoproteins in the formation of the fibrous plaque
7. Recent advances in experimental and molecular pathology; Influx, synthesis, and transport of arterial lipoproteins in atherosclerosis
8. Local intimal-medial uptakes of 125I-albumin, 125I-LDL, and parenteral Evans blue dye protein complex along the aortas of normocholesterolemic minipigs as predictors of subsequent hypercholesterolemic atherogenesis
9. Fibrin deposition and fibrin degradation products in atherosclerotic plaques
10. Haemostatic factors in human aortic intima
11. Visualization and quantification of transmural concentration profiles of macromolecules across the arterial wall
12. The response-to-retention hypothesis of early atherogenesis
13. Smooth muscle cells in atherosclerosis
14. A corrective histochemical, biochemical and electron microscopic study of experimental atherosclerosis in the rabbit aorta with special references to the myo-intimal cell
15. Experimental aortic intimal thickening. I. Morphology and source of intimal cells
16. Atherosclerosis - an inflammatory disease
17. Update on the pathogenesis of atherosclerosis
18. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration
19. The pathogenesis of atherosclerosis: A perspective for the 1990's
20. Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque
21. The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions
22. Peripheral vascular stenosis in apolipoprotein E-deficient mice. Potential roles of lipid deposition, medial atrophy, and adventitial inflammation
23. Natural history and histological classification of atherosclerotic lesions: An update
24. Assessment of factors important in atherosclerotic occlusion and restenosis
25. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury
26. Impaired arterial neointima formation in mice with disruption of the plasminogen gene
27. Reduced transplant arteriosclerosis in plasminogen-deficient mice
28. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model
29. Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1
30. The intima. Soil for atherosclerosis and restenosis
31. Intimal hyperplasia of the infant parasellar carotid artery: A potential developmental factor in atherosclerosis and SIDS
32. Neonatal intima formation in the human coronary artery
33. Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus
34. Elastin is an essential determinant of arterial morphogenesis
35. Vascular remodeling in the growth hormone transgenic mouse
36. Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation
37. Changes in endothelial cell and smooth muscle cell integrin expression during closure of the ductus arteriosus: An immunohistochemical comparison of the fetal, preterm newborn, and full-term newborn rhesus monkey ductus
38. Role of beta1 and beta3 integrins in human smooth muscle cell adhesion to and contraction of fibrin clots in vitro
39. Human carotid artery smooth muscle cells rarely express αvβ3 integrin at sites of recent plaque rupture
40. Monoclonality in atherosclerosis may arise by expansion of a pre-existing clone of smooth muscle cells
41. Clonal architecture of normal and atherosclerotic aorta: Implications for atherogenesis and vascular development
42. Sequential injury of the rabbit abdominal aorta induces intramural coagulation and luminal narrowing independent of intimal mass: Extrinsic pathway inhibition eliminates luminal narrowing
43. Elucidation of the role of plaque instability and rupture in acute coronary events
44. Blood-borne tissue factor: Another view of thrombosis
45. Some thoughts about localization and expression of tissue factor
46. Coronary plaque disruption
47. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgey Study (CASS). CASS Participating Investigators and Staff
48. Progression of coronary atherosclerosis: Is coronary spasm related to progression?
49. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography
50. Angiographic evolution of coronary artery morphology in unstable angina
51. Anatomic features in victims of sudden coronary death. Coronary artery pathology
52. Familial hypercholesterolemia associated with coronary atherosclerosis in swine bearing different alleles for apolipoprotein B
53. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice
54. Pathology of coronary atherosclerosis: Implications for intravascular ultrasound imaging
55. Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions
56. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice
57. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice
58. Microscopic localization of active proteases by in situ zymography: Detection of matrix metalloproteinase activity in vascular tissue
59. Expression of stromelysin-3 in atherosclerotic lesions: Regulation via CD40-CD40 ligand signaling in vitro and in vivo
60. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques
61. Modification of proteins and lipids by myeloperoxidase
62. Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1- antichymotrypsin by oxidatively activated human neutrophil metalloproteinases
63. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
64. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells
65. Evidence for presence and function of Fas and Fas-ligand in the vessel wall: Mediation of smooth muscle cell apoptosis in human coronary atherosclerosis
66. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease
67. Proliferative activity in coronary atherectomy tissue. Clinical, histopathologic, and immunohistochemical correlates
68. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for anti-proliferative therapy
69. Cell proliferation in human coronary arteries
70. Thrombin stimulates PDGF production and monocyte adhesion through distinct intracellular pathways in human endothelial cells
71. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages
72. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils
73. The Rokitanski-Duguid project
74. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin
75. Amino acid sequence studies on the alpha chain of human fibrinogen. Overlapping sequences providing the complete sequence
76. Amino acid sequence of the beta chain of human fibrinogen
77. Trinodular structure of fibrinogen. Confirmation by both shadowing and negative stain electron microscopy
78. Coagulant activity of leukocytes. Tissue factor activity
79. Cultured human endothelial cells generate tissue factor in response to endotoxin
80. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
81. Tissue factor-dependent autoactivation of human blood coagulation factor VII
82. The mechanism of activation of factor X. Kinetic control of alternative pathways leading to the formation of activated factor X
83. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes
84. Structure of the fibrin protofibril
85. An electron microscopic investigation of the polymerization of bovine fibrin monomer
86. Determination of the topology of factor XIIIa-induced fibrin gamma- chain cross-links by electron microscopy of ligated fragments
87. Cross-link in fibrin polymerized by factor 13: Epsilon-(gamma- glutamyl)lysine
88. Alpha(1)-proteinase inhibitor, alpha(1)-antichymotrypsin, or alpha(2)-macroglobulin is required for vascular smooth muscle cell spreading in three-dimensional fibrin Gel
89. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies
90. Visualization of apo B, fibrinogen/fibrin, and fibronectin in the intima of normal human aorta and large arteries and during atherosclerosis
91. Immunodetection of human atherosclerotic plaque with 125I-labeled monoclonal antifibrin antibodies
92. Tissue factor in the pathogenesis of atherosclerosis
93. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
94. Patterns of fibrin deposits in carotid artery plaques
95. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: Effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions
96. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity
97. Tissue factor pathway inhibitor expression in atherosclerosis
98. Thrombin generation by apoptotic vascular smooth muscle cells
99. Apoptic vascular endothelial cells become procoagulant
100. Tissue factor de-encryption: Ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms
101. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant
102. Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas
103. Coronary thrombosis in non-cardiac death
104. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
105. Coronary plaque erosion without rupture into a lipid core: A frequent cause of coronary thrombosis in sudden coronary death
106. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction
107. Effect of hypertension and cardiac hypertrophy on coronary artery morphology in sudden cardiac death
108. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly
109. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women
110. Coronary calcification: Insights from sudden coronary death victims
111. Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits
112. Vascular reactivity during the progression of atherosclerotic plaque. A study in Watanabe heritable hyperlipidemic rabbits
113. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries
114. Surface ultrastructure of human arteries with special reference to the effects of smoking
115. Nicotine and cigarette smoking: Effects on the ultrastructure of aortic endothelium
116. Scanning electron microscopy in the evaluation of endothelial integrity of the fatty lesion in atherosclerosis
117. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study
118. Histopathology of postpercutaneous transluminal coronary angioplasty remodeling in human coronary arteries
119. Compensatory enlargement of human atherosclerotic coronary arteries
120. Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1 beta
121. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: Insights from a porcine coronary (re)stenosis model
122. Plaque rupture and sudden death related to exertion in men with coronary artery disease
123. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death
124. Effects of beta3-integrin blockade (c7E3) on the response to angioplasty and intra-arterial stenting in atherosclerotic nonhuman primates
125. Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: Evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during neointima formation
126. Cell adhesion molecules in coronary artery disease
127. Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA
128. v3 integrin expression in normal and atherosclerotic artery
129. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening following endothelial denudation
130. Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells
131. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation
132. Kistrin inhibits human smooth muscle cell interaction with fibrin
133. Changes in expression and organization of smooth muscle-specific alpha-actin during fibronectin-mediated modulation of arterial smooth muscle cell phenotype
134. Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fibronectin
135. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors